Coagulative Disorders in HIV-Infected Patients

  • L. Drouet


Coagulative disorders in human immunodeficiency virus (HIV)-infected patients can lead to two opposite conditions:
  1. 1.

    Thrombotic conditions;

  2. 2.

    Hemorrhagic conditions.



Thrombotic Thrombocytopenic Purpura Retinal Vein Occlusion Central Retinal Vein Occlusion Cerebral Venous Thrombosis Patient Receive Protease Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koppel K, Bratt G, Schulman S, Bylund H, Sandstrom E (2002) Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 29:441–449PubMedGoogle Scholar
  2. 2.
    Hadigan C, Meigs JB, Rabe J et al (2001) Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 86:939–943CrossRefPubMedGoogle Scholar
  3. 3.
    Yki-Jarvinen H, Sutinen J, Silveira A et al (2003) Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 23:688–694CrossRefPubMedGoogle Scholar
  4. 4.
    Drouet L, Scrobohaci ML, Janier M, Baudin B (1990) Endothelial cells: target for the HIV1 virus? Nouv Rev Fr Hematol 32:103–106PubMedGoogle Scholar
  5. 5.
    Aukrust P, Bjornsen S, Lunden B et al (2000) Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy. Thromb Haemost 84:183–187Google Scholar
  6. 6.
    Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M (2002) Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 185:456–462CrossRefPubMedGoogle Scholar
  7. 7.
    Miguez-Burbano MJ, Burbano X, Rodriguez A, Lecusay R, Rodriguez N, Shor-Posner G (2002) Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy. Platelets 13:183–185CrossRefPubMedGoogle Scholar
  8. 8.
    Saif MW, Greenberg B (2001) HIV and thrombosis: a review. AIDS Patient Care STDS 15:15–24CrossRefPubMedGoogle Scholar
  9. 9.
    Sullivan PS, Dworkin MS, Jones JL, Hooper WC (2000) Epidemiology of thrombosis in HIVinfected individuals: The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 14:321–324CrossRefPubMedGoogle Scholar
  10. 10.
    Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R et al (2004) Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 10:19–25CrossRefPubMedGoogle Scholar
  11. 11.
    Callens S, Florence E, Philippe M, Van Der PM, Colebunders R (2003) Mixed arterial and venous thromboembolism in a person with HIV infection. Scand J Infect Dis 35:907–908CrossRefPubMedGoogle Scholar
  12. 12.
    Becker DM, Saunders TJ, Wispelwey B, Schain DC (1992) Case report: venous thromboembolism in AIDS. Am J Med Sci 303:395–397CrossRefPubMedGoogle Scholar
  13. 13.
    Tanimowo M (1996) Deep vein thrombosis as a manifestation of the acquired immunodeficiency syndrome? A case report. Cent Afr J Med 42:327–328PubMedGoogle Scholar
  14. 14.
    Vielhauer V, Schewe CK, Schlondorff D (1998) Bilateral thrombosis of the internal jugular veins with spasmodic torticollis in a patient with acquired immunodeficiency syndrome and disseminated cytomegalovirus infection. J Infect 37:90–91CrossRefPubMedGoogle Scholar
  15. 15.
    Bayer DD, Sorbello AF, Condoluci DV (1995) Bilateral subclavian vein thrombosis in a patient with acquired immunodeficiency syndrome. J Am Osteopath Assoc 95:276–277PubMedGoogle Scholar
  16. 16.
    Laing RB, Brettle RP, Leen CL (1996) Venous thrombosis in HIV infection. Int J STD AIDS 7:82–85CrossRefPubMedGoogle Scholar
  17. 17.
    Meyohas MC, Roullet E, Rouzioux C et al (1989) Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 52:1010–1011CrossRefPubMedGoogle Scholar
  18. 18.
    Carr A, Brown D, Cooper DA (1997) Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS 11:1657–1658PubMedGoogle Scholar
  19. 19.
    Narayanan TS, Narawane NM, Phadke AY, Abraham P (1998) Multiple abdominal venous thrombosis in HIV-seropositive patients. Indian J Gastroenterol 17:105–106PubMedGoogle Scholar
  20. 20.
    Roberts SP, Haefs TM (1992) Central retinal vein occlusion in a middle-aged adult with HIV infection. Optom Vis Sci 69:567–569CrossRefPubMedGoogle Scholar
  21. 21.
    Mansour AM, Li H, Segal EI (1996) Picture resembling hemicentral retinal vein occlusion in the acquired immunodeficiency syndrome: is it related to cytomegalovirus? Ophthalmologica 210:108–111PubMedGoogle Scholar
  22. 22.
    Park KL, Marx JL, Lopez PF, Rao NA (1997) Noninfectious branch retinal vein occlusion in HIV-positive patients. Retina 17:162–164PubMedGoogle Scholar
  23. 23.
    Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL (1993) Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 81:1801–1807PubMedGoogle Scholar
  24. 24.
    Bissuel F, Berruyer M, Causse X, Dechavanne M, Trepo C (1992) Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 5:484–489PubMedGoogle Scholar
  25. 25.
    Toulon P, Lamine M, Ledjev I et al (1993) Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus. Thromb Haemost 70:730–735PubMedGoogle Scholar
  26. 26.
    Muller MM, Griesmacher A (2000) Markers of endothelial dysfunction. Clin Chem Lab Med 38:77–85CrossRefPubMedGoogle Scholar
  27. 27.
    Gujuluva C, Burns AR, Pushkarsky T et al (2001) HIV-1 penetrates coronary artery endothelial cells by transcytosis. Mol Med 7:169–176PubMedGoogle Scholar
  28. 28.
    Madalosso C, de SN Jr, Ilstrup DM et al (1998) Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 66:294–297CrossRefPubMedGoogle Scholar
  29. 29.
    Kaukoranta-Tolvanen SS, Ronni T, Leinonen M et al (1996) Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog 21:407–411CrossRefPubMedGoogle Scholar
  30. 30.
    Zhong DS, Lu XH, Conklin BS et al (2002) HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol 22:1560–1566CrossRefPubMedGoogle Scholar
  31. 31.
    Stimmler MM, Quismorio FP Jr, McGehee WG et al (1989) Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 149:1833–1835CrossRefPubMedGoogle Scholar
  32. 32.
    Karmochkine M, Raguin G (1998) Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir. AIDS 12:2499PubMedGoogle Scholar
  33. 33.
    Ankri A, Bonmarchand M, Coutellier A, Herson S, Karmochkine M (1999) Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients. AIDS 13:1282–1283CrossRefPubMedGoogle Scholar
  34. 34.
    Feffer SE, Fox RL, Orsen MM et al (1995) Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 88:1126–1130PubMedGoogle Scholar
  35. 35.
    Force L, Barrufet P, Herreras Z, Bolibar I (1999) Deep venous thrombosis and megestrol in patients with HIV infection. AIDS 13:1425–1426CrossRefPubMedGoogle Scholar
  36. 36.
    Hirsh J, Hull RD, Raskob GE (1986) Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol 8(6 Suppl B):104B–113BPubMedCrossRefGoogle Scholar
  37. 37.
    Kaufmann T, Nisce LZ, Metroka C (1991) Thromboembolism in AIDS-related Kaposi’s sarcoma. JAMA 266:2834CrossRefPubMedGoogle Scholar
  38. 38.
    Heit JA (2002) Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 28(Suppl 2):3–13CrossRefPubMedGoogle Scholar
  39. 39.
    Biswas J, Roy CB, Krishna KS et al (2001) Detection of Mycobacterium tuberculosis by polymerase chain reaction in a case of orbital tuberculosis. Orbit 20:69–74CrossRefPubMedGoogle Scholar
  40. 40.
    Friedman SM, Margo CE (1995) Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathologic correlation. Arch Ophthalmol 113:1184–1188Google Scholar
  41. 41.
    Iranzo A, Domingo P, Cadafalch J, Sambeat MA (1998) Intracranial venous and dural sinus thrombosis due to protein S deficiency in a patient with AIDS. J Neurol Neurosurg Psychiatry 64:688CrossRefPubMedGoogle Scholar
  42. 42.
    Biswas J, Kumar AA, George AE et al (2000) Ocular and systemic lesions in children with HIV. Indian J Pediatr 67:721–724CrossRefPubMedGoogle Scholar
  43. 43.
    Kleinschmidt-DeMasters BK, Mazowiecki M, Bonds LA et al (2000) Coccidioidomycosis meningitis with massive dural and cerebral venous thrombosis and tissue arthroconidia. Arch Pathol Lab Med 124:310–314PubMedGoogle Scholar
  44. 44.
    Doberson MJ, Kleinschmidt-DeMasters BK (1994) Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 118:844–846PubMedGoogle Scholar
  45. 45.
    Abuaf N, Laperche S, Rajoely B et al (1997) Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 77:856–861PubMedGoogle Scholar
  46. 46.
    Shahnaz S, Parikh G, Opran A (2004) Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am J Med Sci 327:231–232CrossRefPubMedGoogle Scholar
  47. 47.
    Ramos-Casals M, Cervera R, Lagrutta M et al (2004) Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38:1009–1016CrossRefPubMedGoogle Scholar
  48. 48.
    Sugerman RW, Church JA, Goldsmith JC, Ens GE (1996) Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 15:106–111CrossRefPubMedGoogle Scholar
  49. 49.
    Melchior JC, Messing B (1999) Home parenteral nutrition in acquired immunodeficiency syndrome patients. Nutrition 15:68–69CrossRefPubMedGoogle Scholar
  50. 50.
    Duerksen DR, Ahmad A, Doweiko J et al (1996) Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 20:302–305CrossRefPubMedGoogle Scholar
  51. 51.
    George SL, Swindells S, Knudson R, Stapleton JT (1999) Unexplained thrombosis in HIVinfected patients receiving protease inhibitors: report of seven cases. Am J Med 107:624–630CrossRefPubMedGoogle Scholar
  52. 52.
    Wilde JT, Lee CA, Collins P et al (1999) Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders. Br J Haematol 107:556–559CrossRefPubMedGoogle Scholar
  53. 53.
    Llibre JM, Romeu J, Lopez E, Sirera G (2002) Severe interaction between ritonavir and acenocoumarol. Ann Pharmacother 36:621–623CrossRefPubMedGoogle Scholar
  54. 54.
    Rerolle JP, Canaud G, Fakhouri F et al (2004) Thrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection. Scand J Infect Dis 36:234–237CrossRefPubMedGoogle Scholar
  55. 55.
    Gervasoni C, Ridolfo AL, Vaccarezza M et al (2002) Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 35:1534–1540CrossRefPubMedGoogle Scholar
  56. 56.
    Gruszecki AC, Wehrli G, Ragland BD et al (2002) Management of a patient with HIV infectioninduced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura. Am J Hematol 69:228–231CrossRefPubMedGoogle Scholar
  57. 57.
    Scaradavou A (2002) HIV-related thrombocytopenia. Blood Rev 16:73–76CrossRefPubMedGoogle Scholar
  58. 58.
    Burbano X, Miguez MJ, Lecusay R et al (2001) Thrombocytopenia in HIV-infected drug users in the HAART era. Platelets 12:456–461CrossRefPubMedGoogle Scholar
  59. 59.
    Carbonara S, Fiorentino G, Serio G et al (2001) Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors. J Infect 42:251–256CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • L. Drouet
    • 1
  1. 1.Laboratoire de Thrombose et d’AthéroscléroseHôpital LariboisièreParisFrance

Personalised recommendations